+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Antibody Drug Conjugates (ADC) - Global Strategic Business Report - Product Thumbnail Image

Antibody Drug Conjugates (ADC) - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
Combination Antibody Therapy - Global Strategic Business Report - Product Thumbnail Image

Combination Antibody Therapy - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Gynecological Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Gynecological Cancer Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
Endometrial Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Endometrial Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 192 Pages
  • Global
From
Leukemia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Leukemia Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • November 2024
  • 224 Pages
  • Global
From
Immune Checkpoint Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Immune Checkpoint Inhibitors - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Malignant Mesothelioma - Global Strategic Business Report - Product Thumbnail Image

Malignant Mesothelioma - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
From
Non-Melanoma Skin Cancer - Global Strategic Business Report - Product Thumbnail Image

Non-Melanoma Skin Cancer - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
Sunitinib Malate - Global Strategic Business Report - Product Thumbnail Image

Sunitinib Malate - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
NDDS in Cancer Therapy - Global Strategic Business Report - Product Thumbnail Image

NDDS in Cancer Therapy - Global Strategic Business Report

  • Report
  • November 2024
  • 196 Pages
  • Global
From
From
Metastatic Bone Disease - Global Strategic Business Report - Product Thumbnail Image

Metastatic Bone Disease - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Particle Therapy - Global Strategic Business Report - Product Thumbnail Image

Particle Therapy - Global Strategic Business Report

  • Report
  • November 2024
  • 83 Pages
  • Global
From
Sarcoma Drugs - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
Brain Tumor Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Brain Tumor Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 182 Pages
  • Global
From
From
From
Cervical Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Cervical Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more